Delving into the Latest Updates on Bruschettini Srl with Synapse

Open Label Extension Study to Investigate Long Term Safety, Tolerability and Efficacy of Tauroursodeoxycholic Acid in Patients With ALS Who Completed the TUDCA-ALS Study

This study will provide extended access to patients and assess longer-term outcomes on patients who have completed the TUDCA-ALS study.

开始日期2021-10-25

申办/合作机构

Humanitas Mirasole SpA

[+9]

EUCTR2011-003239-76-IT

/ Completed临床4期

Efficacy and tolerability clinical trial of Lantigen B (A bacterial lysate having immunostimulating activity) in the prophylaxis of respiratory infections, with special reference to patients with allergy to perennial inhalants. Double-blind multicenter, randomized study vs. placebo.

开始日期2012-05-07

申办/合作机构

Bruschettini Srl

100 项与 Bruschettini Srl 相关的临床结果

登录后查看更多信息

0 项与 Bruschettini Srl 相关的专利（医药）

登录后查看更多信息

1

项与 Bruschettini Srl 相关的新闻（医药）

2022-07-18

·SYNAPSE

PIAM Farmaceutici acquisisce il 100% di Bruschettini

Deloitte Legal ha assistito PIAM Farmaceutici sia per gli aspetti corporate sia per la negoziazione dell’Acquisition Financing.PIAM Farmaceutici S.p.a. ha acquistato il 100% di Bruschettini, in…

100 项与 Bruschettini Srl 相关的药物交易

登录后查看更多信息

100 项与 Bruschettini Srl 相关的转化医学

登录后查看更多信息